Bioworkshops sell "Bevacizumab"
Basic Information
27
1
4.6(70)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Bevacizumab
Manufacturer(s)
Specifications
- Expression System: Mammalian (CHO-type) cell line optimized for high-titer bevacizumab (anti-VEGF-A mAb) expression
- Application: Biosimilar cell-line platform for bevacizumab manufacturing; target indications include colorectal and rectal cancer
- Regulatory Status: Supported by DMF filing for global regulatory readiness; reference product originally approved by US FDA in 2004
Documents
GMP
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment